Schmitt NC - Search Results

1

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.

Greene S, Robbins Y, Mydlarz WK, Huynh AP, Schmitt NC, Friedman J, Horn LA, Palena C, Schlom J, Maeda DY, Zebala JA, Clavijo PE, Allen C. Greene S, et al. Among authors: schmitt nc. Clin Cancer Res. 2020 Mar 15;26(6):1420-1431. doi: 10.1158/1078-0432.CCR-19-2625. Epub 2019 Dec 17. Clin Cancer Res. 2020. PMID: 31848188 Free PMC article.

2

Characterization of human papillomavirus antibodies in individuals with head and neck cancer.

Lang Kuhs KA, Pawlita M, Gibson SP, Schmitt NC, Trivedi S, Argiris A, Kreimer AR, Ferris RL, Waterboer T. Lang Kuhs KA, et al. Among authors: schmitt nc. Cancer Epidemiol. 2016 Jun;42:46-52. doi: 10.1016/j.canep.2016.03.003. Epub 2016 Mar 21. Cancer Epidemiol. 2016. PMID: 27010729 Free PMC article.

3

PD-1 Status in CD8⁺ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.

Kansy BA, Concha-Benavente F, Srivastava RM, Jie HB, Shayan G, Lei Y, Moskovitz J, Moy J, Li J, Brandau S, Lang S, Schmitt NC, Freeman GJ, Gooding WE, Clump DA, Ferris RL. Kansy BA, et al. Among authors: schmitt nc. Cancer Res. 2017 Nov 15;77(22):6353-6364. doi: 10.1158/0008-5472.CAN-16-3167. Epub 2017 Sep 13. Cancer Res. 2017. PMID: 28904066 Free PMC article.

4

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma.

Tran L, Allen CT, Xiao R, Moore E, Davis R, Park SJ, Spielbauer K, Van Waes C, Schmitt NC. Tran L, et al. Among authors: schmitt nc. Cancer Immunol Res. 2017 Dec;5(12):1141-1151. doi: 10.1158/2326-6066.CIR-17-0235. Epub 2017 Nov 2. Cancer Immunol Res. 2017. PMID: 29097421 Free PMC article.

5

Radiation-Associated Sarcoma of the Neck: Case Series and Systematic Review.

Williams L, Tmanova L, Mydlarz WK, Page B, Richmon JD, Quon H, Schmitt NC. Williams L, et al. Among authors: schmitt nc. Ann Otol Rhinol Laryngol. 2018 Oct;127(10):735-740. doi: 10.1177/0003489418789966. Epub 2018 Jul 26. Ann Otol Rhinol Laryngol. 2018. PMID: 30047787 Review.

6

Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer.

Xiao R, Allen CT, Tran L, Patel P, Park SJ, Chen Z, Van Waes C, Schmitt NC. Xiao R, et al. Among authors: schmitt nc. Oncoimmunology. 2018 Aug 1;7(9):e1471440. doi: 10.1080/2162402X.2018.1471440. eCollection 2018. Oncoimmunology. 2018. PMID: 30393585 Free PMC article.

7

Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV^- and HPV⁺ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy.

Xiao R, An Y, Ye W, Derakhshan A, Cheng H, Yang X, Allen C, Chen Z, Schmitt NC, Van Waes C. Xiao R, et al. Among authors: schmitt nc. Clin Cancer Res. 2019 Nov 1;25(21):6463-6474. doi: 10.1158/1078-0432.CCR-18-3802. Epub 2019 Jul 2. Clin Cancer Res. 2019. PMID: 31266830 Free PMC article.

8

Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.

Park SJ, Ye W, Xiao R, Silvin C, Padget M, Hodge JW, Van Waes C, Schmitt NC. Park SJ, et al. Among authors: schmitt nc. Oral Oncol. 2019 Aug;95:127-135. doi: 10.1016/j.oraloncology.2019.06.016. Epub 2019 Jun 20. Oral Oncol. 2019. PMID: 31345380 Free PMC article.

9

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.

Friedman J, Moore EC, Zolkind P, Robbins Y, Clavijo PE, Sun L, Greene S, Morisada MV, Mydlarz WK, Schmitt N, Hodge JW, Schreiber H, Van Waes C, Uppaluri R, Allen C. Friedman J, et al. Clin Cancer Res. 2020 Feb 1;26(3):679-689. doi: 10.1158/1078-0432.CCR-19-2209. Epub 2019 Oct 23. Clin Cancer Res. 2020. PMID: 31645352 Free PMC article.

10

ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer.

Ye W, Gunti S, Allen CT, Hong Y, Clavijo PE, Van Waes C, Schmitt NC. Ye W, et al. Among authors: schmitt nc. Oncoimmunology. 2020 Jan 9;9(1):1710398. doi: 10.1080/2162402X.2019.1710398. eCollection 2020. Oncoimmunology. 2020. PMID: 32002309 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page